Pharmacokinetics of midazolam in critically ill neonates
- 1 August 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 39 (2) , 191-192
- https://doi.org/10.1007/bf00280059
Abstract
Midazolam is a water soluble benzodiazepine, with a short elimination half-life in adults and children. An IV bolus of midazolam 0.2 mg · kg−1 was administered to 10 critically ill neonates receiving intensive care who required sedation. The plasma clearance was 6.85 ml · min−1 and the elimination half-life was 6.52 h. Midazolam was well tolerated during and after administration. Because of its short half-life compared to diazepam, midazolam could be used during the neonatal period to produce brief rapid sedation.Keywords
This publication has 14 references indexed in Scilit:
- The pharmacokinetics of midazolam in paediatric patientsEuropean Journal of Clinical Pharmacology, 1989
- Pain and Its Effects in the Human Neonate and FetusNew England Journal of Medicine, 1987
- The Pharmacokinetics of Rectal Midazolam for Premedication in ChildrenAnesthesiology, 1986
- MidazolamAnesthesiology, 1985
- Determination of midazolam (versed®) and its metabolites in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- A multicenter study of ICU drug utilizationIntensive Care Medicine, 1981
- Clinical Pharmacokinetics in Newborns and Infants Age-related Differences and Therapeutic ImplicationsClinical Pharmacokinetics, 1980
- Glomerular filtration rate in the first three weeks of lifeThe Journal of Pediatrics, 1975
- Hepatic microsomal drug oxidation and electron transport in newborn infantsThe Journal of Pediatrics, 1974
- Diazepam elimination in premature and full term infants, and childrenjpme, 1973